These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9409939)

  • 1. [Thromboembolic risk in chronic cardiac insufficiency].
    Tavazzi L
    Rev Port Cardiol; 1997 Sep; 16(9):723-4. PubMed ID: 9409939
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atrial fibrillation. Risk of thromboembolic complications and their prevention].
    Petersen P; Kastrup J; Bartram R; Godtfredsen J
    Ugeskr Laeger; 1984 Mar; 146(11):789-92. PubMed ID: 6719572
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anticoagulant treatment and cardiac insufficiency].
    Bounhoure JP; Galinier M; Pathak A
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():29-32. PubMed ID: 10830086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Actual Issues of Choosing Anticoagulant Therapy for Long-term Prophylaxis of Thromboembolic Complications].
    Duplyakov VD; Pavlova VT; Voronova LI
    Kardiologiia; 2017 Aug; 57(8):71-79. PubMed ID: 29041895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute management of atrial fibrillation: Part II. Prevention of thromboembolic complications.
    King DE; Dickerson LM; Sack JL
    Am Fam Physician; 2002 Jul; 66(2):261-4. PubMed ID: 12152961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation in patients with atrial fibrillation and congestive heart failure.
    Veloso HH; de Paola AA
    Am J Cardiol; 2005 Jun; 95(12):1533. PubMed ID: 15950594
    [No Abstract]   [Full Text] [Related]  

  • 7. Heart Failure, Nonvalvular Atrial Fibrillation and Anticoagulation Control With Vitamin K Antagonists.
    Anguita Sánchez M; Bertomeu Martínez V; Cequier Fillat Á;
    Rev Esp Cardiol (Engl Ed); 2016 Jan; 69(1):75-6. PubMed ID: 26589883
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation.
    Watson T; Shantsila E; Lip GY
    Int J Cardiol; 2007 Aug; 120(1):123-4; author reply 125-6. PubMed ID: 17055595
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
    Pengo V; De Caterina R
    Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thromboembolic risk in atrial fibrillation: new clinical perspectives].
    Villani GQ; Andreoli AM; Villani M; Capucci A
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):22S-26S. PubMed ID: 19195302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism].
    Vink R; van den Brink RB; Levi M
    Ned Tijdschr Geneeskd; 2002 Nov; 146(48):2285-9. PubMed ID: 12497755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting thromboembolism and selecting patients for anticoagulant therapy in atrial fibrillation.
    Weintraub WS
    J Am Coll Cardiol; 2008 Feb; 51(8):816-7. PubMed ID: 18294565
    [No Abstract]   [Full Text] [Related]  

  • 15. Balancing risk in atrial fibrillation.
    Ali SN; Hardman SM
    Practitioner; 2001 May; 245(1622):357. PubMed ID: 11373966
    [No Abstract]   [Full Text] [Related]  

  • 16. Should we use anticoagulation for patients with chronic heart failure?
    Freudenberger RS; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):580-1. PubMed ID: 17063158
    [No Abstract]   [Full Text] [Related]  

  • 17. Atrial fibrillation--rate versus rhythm control.
    Manning WJ
    N Engl J Med; 2003 Mar; 348(13):1284-6; author reply 1284-6. PubMed ID: 12661569
    [No Abstract]   [Full Text] [Related]  

  • 18. [Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
    J Cardiol; 1998 Apr; 31(4):227-38. PubMed ID: 9594372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
    Blich M; Gross B
    Int J Cardiol; 2004 Jul; 96(1):89-95. PubMed ID: 15203266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticoagulant therapy in patients with dilated cardiomyopathy].
    Gensini GF; Rostagno C
    Ann Ital Med Int; 1998; 13(4):227-32. PubMed ID: 10349204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.